logo
Plus   Neg
Share
Email

Quest Diagnostics Continues To Post Steep Loss In Late-Day Trading

Shares of Quest Diagnostics Inc. (DGX) continue to see substantial weakness in late-day trading on Thursday after falling sharply early in the session. After hitting a two-year intraday low, Quest Diagnostics is currently down by 9.2 percent.

Quest Diagnostics initially came under pressure after the lab testing services provider lowered its full-year earnings and revenue forecast.

The company said it now expects full-year earnings greater than $6.30 per share on revenues of approximately $7.57 billion compared to its previous forecast for earnings of $6.53 to $6.60 per share on revenues of around $7.62 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fiat Chrysler Automobiles N.V. (FCAU) has submitted a 50/50 merger proposal to the Board of Groupe Renault (RNSDY.PK, RNSDF.PK, RNT.L). Under the proposal, the combined company would be owned 50% by FCA shareholders and 50% by Groupe Renault shareholders. Separately, Groupe Renault confirmed it has received... Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020.